by Alex Brown | Oct 20, 2023 | News
Meet with Vici at AAPS 2023 PharmSci 360 Are you looking for a high quality, US-based, full service R&D focused CDMO to accelerate your drug development program? Meet with our CEO, Dr Anish Dhanarajan and Senior Director of R&D, Dr Suneel Rastogi at AAPS next...
by Alex Brown | Sep 18, 2023 | Blog
In the ever-evolving landscape of pharmaceuticals and drug discovery, researchers are constantly on the lookout for innovative compounds that can target diseases more effectively with fewer side effects. One class of compounds that continues to be critical in this...
by Alex Brown | Sep 14, 2023 | Blog
Early Preformulation Studies For the development of a robust suspension product, several factors must be considered early on during product development. These include API particle size, particle density, viscosity and specific gravity of the media, buffer capacity,...
by Alex Brown | Aug 29, 2023 | News
Vici will be exhibiting at the 22nd Annual Contract Pharma Conference September 21-22, 2023 Hyatt Regency, New Brunswick NJ. As a proud Gold Level Sponsor of the event, Vici invites you to Table 101 to understand your pharmaceutical R&D needs and discuss how we...
by Alex Brown | Aug 29, 2023 | Blog
What are Pharmaceutical Suspensions Liquid oral dosage forms such as solutions and suspensions are often preferred for pediatric or geriatric patients that find it difficult to swallow tablets or capsules. Most pharmaceutical suspensions are coarse dispersions of...
